Keyphrases
Adverse Effects
100%
Female Rats
100%
Adolescent Females
100%
Methylphenidate
100%
Reproductive Axis
100%
Pituitary
60%
Estrous Cyclicity
60%
Growth Differentiation Factor 9 (GDF9)
40%
Activin Receptor
40%
Immunocytochemistry
20%
Sprague-Dawley Rats
20%
Research Laboratories
20%
Saline Control
20%
LH Release
20%
Ovarian Follicle
20%
Female Reproductive
20%
University Research
20%
Physiological Saline
20%
Vaginal Progesterone
20%
Subcutaneous Implantation
20%
Vaginal Opening
20%
Ovarian Follicular Development
20%
Adolescent Health
20%
Prepubertal Females
20%
Pubertal Onset
20%
Vaginal Estrogen
20%
Minipump
20%
Pump Implantation
20%
Cupertino
20%
Ovarian Histology
20%
Biochemistry, Genetics and Molecular Biology
Growth Differentiation Factor-9
100%
Activin Receptor
100%
Adolescence
100%
Immunocytochemistry
50%
Maturation
50%
Sprague Dawley Rat
50%
Prospective Study
50%
Luteinizing Hormone Release
50%
Folliculogenesis
50%
Estrogen Blood Level
50%
Adolescent Health
50%
Progesterone Blood Level
50%
Medicine and Dentistry
Adverse Event
100%
Methylphenidate
100%
Adolescence
100%
Activin Receptor 1
40%
Growth Differentiation Factor 9
40%
Progesterone
20%
Immunocytochemistry
20%
Maturation
20%
Prospective Study
20%
Luteinizing Hormone Release
20%
Ovarian Follicle
20%
Oocyte
20%
Ovary Follicle Development
20%
Adolescent Health
20%
Pituitary
20%
Table Salt
20%
Neuroscience
Adverse Effect
100%
Female Rats
100%
Methylphenidate
100%
Activin Receptor 1
40%
Growth Differentiation Factor-9
40%
Immunocytochemistry
20%
Progesterone
20%
Ovarian Follicle
20%
Ovary Follicle Development
20%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
100%
Methylphenidate
100%
Growth Differentiation Factor 9
40%
Activin Receptor 1
40%
Progesterone
20%
Sprague Dawley Rat
20%
Prospective Study
20%
Table Salt
20%